Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Atara Biotherapeutics | 148.00 Mn | 131.45 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.14% |
| Mar 31, 2026 | -1.18% |
| Dec 31, 2025 | -32.92% |
| Sep 30, 2025 | -18.25% |
| Jun 30, 2025 | -40.52% |
| Mar 31, 2025 | -43.14% |
| Dec 31, 2024 | -23.55% |
| Sep 30, 2024 | 21.68% |
| Jun 30, 2024 | -29.04% |
| Mar 31, 2024 | -0.14% |
| Dec 31, 2023 | -12.33% |
| Sep 30, 2023 | -23.39% |
| Jun 30, 2023 | -18.42% |
| Mar 31, 2023 | -19.75% |
| Dec 31, 2022 | 2.20% |
| Sep 30, 2022 | -15.55% |
| Jun 30, 2022 | 9.78% |
| Mar 31, 2022 | -15.13% |
| Dec 31, 2021 | 4.05% |
| Sep 30, 2021 | -1.50% |